BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND CDK4, PSK-J3, 1019, ENSG00000135446, MGC14458, CMM3, P11802 AND Prognosis
30 results:

  • 1. Trauma plays an important role in acral melanoma: A retrospective study of 303 patients.
    Huang R; Zhao M; Zhang G; Yang Y; Wang J; Zheng K; Li L; Su X; Zhao L; Wu Y; Zou Z
    Cancer Med; 2024 Apr; 13(7):e7137. PubMed ID: 38545846
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Assessment of Social Vulnerability in Pediatric Head and Neck cancer Care and prognosis in the United States.
    Fei-Zhang DJ; Chelius DC; Patel UA; Smith SS; Sheyn AM; Rastatter JC
    JAMA Netw Open; 2023 Feb; 6(2):e230016. PubMed ID: 36800183
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma.
    Huang R; Shen G; Ren Y; Zheng K; Wang J; Shi Y; Yin JC; Qin L; Zhang G; Zhao M; Su X; Li L; Wang F; Shao Y; Liu B; Zou Z
    J Transl Med; 2023 Feb; 21(1):78. PubMed ID: 36739402
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Eight Cases of Breast cancer That Relapsed More Than Ten Years after Initial Treatment].
    Yoshimura A; Ueda T; Tanaka T; Kirihataya Y; Soga M; Yokotani T
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1935-1937. PubMed ID: 36733049
    [TBL] [Abstract] [Full Text] [Related]  

  • 5.
    Liu J; Lin J; Wang X; Zheng X; Gao X; Huang Y; Chen G; Xiong J; Lan B; Chen C; Si L; Chen Y
    Front Immunol; 2022; 13():725679. PubMed ID: 35844619
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Melanocytic lesions of the central nervous system: a case series.
    Varela-Poblete J; Vidal-Tellez A; Cruz-Quiroga JP; Montoya-Salvadores F; Medina-Escobar J
    Arq Neuropsiquiatr; 2022 Feb; 80(2):153-160. PubMed ID: 35352754
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. ZC3H15 Correlates with a Poor prognosis and Tumor Progression in Melanoma.
    Li Q; Hou J; Guo C; Zhang Y; Liu L; Hu H; Shi S; Ji Y; Guo L; Shi Y; Liu Y; Cui H
    Biomed Res Int; 2021; 2021():8305299. PubMed ID: 34988227
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cyclin-dependent kinase 4/6 inhibitors suppress tumor growth in extramammary Paget's disease.
    Kitamura S; Yanagi T; Maeda T; Ujiie H
    Cancer Sci; 2022 Feb; 113(2):802-807. PubMed ID: 34866279
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identification of genes and pathways leading to metastasis and poor prognosis in melanoma.
    Zhang X; Wang W; Wang Y; Jiang G
    Aging (Albany NY); 2021 Sep; 13(18):22474-22489. PubMed ID: 34582363
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. LncRNA BASP1-AS1 interacts with YBX1 to regulate Notch transcription and drives the malignancy of melanoma.
    Li Y; Gao Y; Niu X; Tang M; Li J; Song B; Guan X
    Cancer Sci; 2021 Nov; 112(11):4526-4542. PubMed ID: 34533860
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Targeting cyclin-dependent kinase 4/6 as a therapeutic approach for mucosal melanoma.
    Shi CJ; Xu SM; Han Y; Zhou R; Zhang ZY
    Melanoma Res; 2021 Dec; 31(6):495-503. PubMed ID: 34483306
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Basic Pan-cancer Analysis of the Carcinogenic Effects of Cyclin-Dependent Kinase 4 (cdk4) in Human Surface Tumors.
    Wu J; Deng T; Huang Y; Cheng H
    J Healthc Eng; 2021; 2021():8493572. PubMed ID: 34422248
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. NRAS mutant melanoma: Towards better therapies.
    Randic T; Kozar I; Margue C; Utikal J; Kreis S
    Cancer Treat Rev; 2021 Sep; 99():102238. PubMed ID: 34098219
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. cdk4/6 Inhibitors in Melanoma: A Comprehensive Review.
    Garutti M; Targato G; Buriolla S; Palmero L; Minisini AM; Puglisi F
    Cells; 2021 May; 10(6):. PubMed ID: 34071228
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genetic markers for characterization and prediction of prognosis of melanoma subtypes: a 2021 update.
    Podlipnik S; Potrony M; Puig S
    Ital J Dermatol Venerol; 2021 Jun; 156(3):322-330. PubMed ID: 33982545
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Frequent genetic aberrations in the cell cycle related genes in mucosal melanoma indicate the potential for targeted therapy.
    Xu L; Cheng Z; Cui C; Wu X; Yu H; Guo J; Kong Y
    J Transl Med; 2019 Jul; 17(1):245. PubMed ID: 31358010
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing.
    Miskolczi Z; Smith MP; Rowling EJ; Ferguson J; Barriuso J; Wellbrock C
    Oncogene; 2018 Jun; 37(23):3166-3182. PubMed ID: 29545604
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Immunotherapy of Uveal Melanoma: Vaccination Against cancer.
    Kummer M; Schuler-Thurner B
    Methods Mol Biol; 2017; 1499():273-278. PubMed ID: 27987156
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Molecular Biology and Genetic Mechanisms in the Progression of the Malignant skin Melanoma.
    Pejkova S; Dzokic G; Tudzarova-Gjorgova S; Panov S
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2016 Nov; 37(2-3):89-97. PubMed ID: 27883322
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Current Status of Biological Therapies for the Treatment of Metastatic Melanoma.
    Tang T; Eldabaje R; Yang L
    Anticancer Res; 2016 Jul; 36(7):3229-41. PubMed ID: 27354579
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.